InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register account icon
S&P 500
5,544.59
(
-0.78%
)
US TECH 100
19,234.00
(
-0.19%
)
Dow Jones
40,665.02
(
-1.29%
)
Brent Oil
83.90
(
-0.22%
)
Bitcoin
63,569.20
(
-0.62%
)
Post# of 12660
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Gametheory101

Send PM Follow Ignore
Followers 1
Posts 85
Boards Moderated 0
Alias Born 08/19/2006

Gametheory101

Re: rancherho post# 1402

Monday, 10/30/2006 8:11:19 AM

Monday, October 30, 2006 8:11:19 AM

Post# of 12660
The company wouldn't know which Provenge preparation was for a placebo arm participant or a Provenge arm participant. They would therefore measure CD54 in all prepared doses and ask for a new leukapheris from any failed batches.

I do not know how the double blind is designed in this patient specific study but it can't be that difficult to place an independent third party between the company and the clinic.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up